Literature DB >> 14533897

Treatment of previable premature ruptured membranes.

Rubén A Quintero1.   

Abstract

We have gained significant experience in the clinical understanding and treatment of PPROM in the last 5 years. From our work we can conclude that iatrogenic PPROM is not only a different entity etiologically, it is also different than spontaneous PPROM in its clinical behavior and response to therapeutic measures. Our current success rate with the amniopatch allows us to suggest that iatrogenic PPROM should no longer be viewed as a devastating complication of pregnancy. Instead, as other investigators corroborate our successful experience with the amniopatch, this procedure might become standard treatment for this unusual but frustrating complication of prenatal intervention. Regarding spontaneous PPROM, our work suggests that perhaps, in a select group of patients (in whom infection has not set in and in whom a smaller and better defined membrane defect might exist), there is the potential for developing a surgical technique that might graft the defect successfully and allow the integrity of the amniotic membrane to be restored. The actual surgical technique, the materials to be used, and the approach (transabdominal versus transcervical) are areas of research for the future. Meanwhile, continued efforts are warranted to decipher whether or not this obstetrical complication can one day be conquered.

Entities:  

Mesh:

Year:  2003        PMID: 14533897     DOI: 10.1016/s0095-5108(03)00050-2

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  4 in total

1.  Continuous amnioinfusion via an epidural catheter following spontaneous membrane rupture: A case report.

Authors:  Abdulkadir Turgut; Selahattin Katar; Muhammet Erdal Sak; Fethiye Gülden Turgut; Alparslan Sahin; Serdar Başaranoğlu; Ahmet Yalınkaya
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-12-01

Review 2.  Biomaterials in fetal surgery.

Authors:  Sally M Winkler; Michael R Harrison; Phillip B Messersmith
Journal:  Biomater Sci       Date:  2019-05-17       Impact factor: 6.843

3.  Injectable candidate sealants for fetal membrane repair: bonding and toxicity in vitro.

Authors:  Grozdana Bilic; Carrie Brubaker; Phillip B Messersmith; Ajit S Mallik; Thomas M Quinn; Claudia Haller; Elisa Done; Leonardo Gucciardo; Steffen M Zeisberger; Roland Zimmermann; Jan Deprest; Andreas H Zisch
Journal:  Am J Obstet Gynecol       Date:  2010-01       Impact factor: 8.661

4.  Trauma induces overexpression of Cx43 in human fetal membrane defects.

Authors:  David W Barrett; Aumie Kethees; Christopher Thrasivoulou; Alvaro Mata; Alex Virasami; Neil J Sebire; Alex C Engels; Jan A Deprest; David L Becker; Anna L David; Tina T Chowdhury
Journal:  Prenat Diagn       Date:  2017-08-01       Impact factor: 3.050

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.